SAI
REGN icon

Savvy Advisors Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Savvy Advisors Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Sell
2,181
-21
-1% -$16.1K 0.05% 304
2025
Q4 		$1.7M Buy
2,202
+260
+13% +$177K 0.05% 259
2025
Q3 		$1.09M Buy
1,942
+357
+23% +$202K 0.05% 255
2025
Q2 		$832K Buy
1,585
+379
+31% +$212K 0.06% 249
2025
Q1 		$765K Sell
1,206
-39
-3% -$26.8K 0.08% 207
2024
Q4 		$887K Buy
+1,245
New +$1.04M 0.11% 159

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Savvy Advisors Inc's REGN Position: Q1 2026 in Review

Savvy Advisors Inc reduced its Regeneron Pharmaceuticals (REGN) stake by 0.95% in Q1 2026, selling an estimated $16.1K and leaving 2,181 shares worth $1.69M. The position accounts for 0.05% of the portfolio, ranked #304.

Savvy Advisors Inc first reported a position in REGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.7M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Savvy Advisors Inc held 2,181 shares of Regeneron Pharmaceuticals worth $1.69M as of Q1 2026.
  • Savvy Advisors Inc sold 21 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $16.1K.
  • Regeneron Pharmaceuticals made up 0.05% of Savvy Advisors Inc's portfolio in Q1 2026, its #304 holding.
  • Savvy Advisors Inc first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Savvy Advisors Inc's Regeneron Pharmaceuticals position peaked at $1.7M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.